42
Participants
Start Date
June 15, 2025
Primary Completion Date
May 15, 2026
Study Completion Date
June 15, 2026
Topical Bromelain
A natural enzyme-based formulation derived from pineapple, bromelain in orabase is being investigated for its anti-inflammatory and wound-healing properties. As a non-steroidal alternative, it offers a potentially safer treatment option with minimal side effects.
0.1% topical triamcinolone acetonide
A corticosteroid-based standard treatment for OLP, triamcinolone acetonide in orabase is used for its strong anti-inflammatory and immunosuppressive effects. It serves as the conventional treatment versus novel therapy in this study
Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase
This novel formulation combines the enzymatic, healing properties of bromelain with the anti-inflammatory property of triamcinolone. It is designed to provide enhanced therapeutic effects through synergistic action, potentially reducing the required corticosteroid dose while improving clinical outcomes.
Cairo University
OTHER